Alkermes (ALKS) CEO granted 88,843 restricted stock units in Form 4

Rhea-AI Filing Summary

POPS RICHARD F reported acquisition or exercise transactions in this Form 4 filing.

Alkermes plc reported that Director and CEO Richard F. Pops received a grant of 88,843 restricted stock units on March 2, 2026. Each unit represents a contingent right to receive one ordinary share. The entire award is scheduled to vest on December 31, 2026 in connection with the company’s previously announced leadership transition.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider POPS RICHARD F

Role Director and CEO, Alkermes plc

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Unit Award	88,843	$0.00	--

Holdings After Transaction: Restricted Stock Unit Award — 88,843 shares (Direct)

Footnotes (1)

1. Each restricted stock unit represents a contingent right to receive one ordinary share. Shares subject to the restricted stock unit award vest in full on 12/31/2026 in connection with the Company's previously announced leadership transition.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

POPS RICHARD F

(Last) (First) (Middle)

CONNAUGHT HOUSE

1 BURLINGTON ROAD

(Street)

DUBLIN 4 IRELAND

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Alkermes plc. [ ALKS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Director and CEO, Alkermes plc

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit Award	(1)	03/02/2026		A		88,843		(2)	(2)	Ordinary Shares	88,843	$0	88,843	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one ordinary share.

2. Shares subject to the restricted stock unit award vest in full on 12/31/2026 in connection with the Company's previously announced leadership transition.

	/s/ Shantale Greenson, attorney-in-fact for Richard F. Pops	03/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Alkermes (ALKS) disclose for Richard F. Pops?

Alkermes disclosed that Director and CEO Richard F. Pops received a grant of 88,843 restricted stock units. The award was recorded on March 2, 2026 and is reported as a grant or other acquisition rather than an open-market share purchase.

How many restricted stock units were granted to the Alkermes CEO?

The Alkermes CEO was granted 88,843 restricted stock units. According to the filing, each unit represents a contingent right to receive one ordinary share, providing potential future equity if vesting conditions are met on the stated vesting date.

When do Richard F. Pops’ Alkermes restricted stock units vest?

The restricted stock units granted to Richard F. Pops vest in full on December 31, 2026. The filing states that this vesting schedule is tied to the company’s previously announced leadership transition, aligning the award with that corporate event.

What does each Alkermes restricted stock unit granted to the CEO represent?

Each restricted stock unit granted to the CEO represents a contingent right to receive one ordinary share of Alkermes. The units convert into shares only upon vesting, as described in the filing’s footnote regarding the structure of the award.

Was there a cash price for the Alkermes CEO restricted stock unit grant?

The filing lists a transaction price per share of $0.0000 for the restricted stock unit grant. This indicates the units were awarded as equity compensation rather than purchased for cash in the market, consistent with typical executive stock-based awards.

Why is the Alkermes CEO’s restricted stock award linked to a leadership transition?

The award’s footnote states that shares subject to the restricted stock unit grant vest in full on 12/31/2026 in connection with the company’s previously announced leadership transition, tying the equity compensation to that specific organizational milestone.